Lilly's turn to pain gathers momentum

05:12 EDT 7 Aug 2017 | BioPharmaDive

Positive data for the drugmaker's other migraine drug lasmiditan adds another late-stage success to an emerging portfolio of new treatments for pain.

Original Article: Lilly's turn to pain gathers momentum


More From BioPortfolio on "Lilly's turn to pain gathers momentum"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pain Disorder
Pain is a feeling (sharp or dull) triggered in the nervous system which can be transient or constant. Pain can be specific to one area of the body eg back, abdomen or chest or more general all over the body eg muscles ache from the flu. Without pain ...